Plasma PrPC and ADAM-10 as novel biomarkers for traumatic brain injury and concussion: a pilot study

References

• Faul M, Xu L, Wald MM, Coronado VG. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002–2006. Atlanta (GA): Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2010
   Google Scholar
• Arciniegas DB, Anderson CA, Topkoff J, McAllister TW. Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment. Neuropsychiatr Dis Treat. 2005;1(4):311–27.
   PubMedGoogle Scholar
• Byrnes KR, Wilson CM, Brabazon F. FDG-PET imaging in mild traumatic brain injury: a critical review. Front Neuroenergetics. 2013;5:13.
   Google Scholar
• Strathmann FG, Schulte S, Goerl K, Petron DJ. Blood-based biomarkers for traumatic brain injury: evaluation of research approaches, available methods and potential utility from the clinician and clinical laboratory perspectives. Clin Biochem. 2014;47(10–11):876–88. doi:10.1016/j.clinbiochem.2014.01.028.
   PubMed Web of Science ®Google Scholar
• Toman E, Harrisson S, Belli T. Biomarkers in traumatic brain injury: a review. J R Army Med Corps. 2016;162(2):103–08. doi:10.1136/jramc-2015-000517.
   PubMed Web of Science ®Google Scholar
• Pham N, Sawyer TW, Wang Y, Jazii FR, Vair C, Taghibiglou C. Primary blast-induced traumatic brain injury in rats leads to increased prion protein in plasma: a potential biomarker for blast-induced traumatic brain injury. J Neurotrauma. 2015;32(1):58–65. doi:10.1089/neu.2014.3471.
   PubMed Web of Science ®Google Scholar
• Pham N, Akonasu H, Shishkin R, Taghibiglou C, Legname G. Plasma soluble prion protein, a potential biomarker for sport-related concussions: a pilot study. PloS One. 2015;10(2):e0117286. doi:10.1371/journal.pone.0117286.
   PubMed Web of Science ®Google Scholar
• Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, Chen L, Villemaire M, Ali Z, Jirik FR. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol. 2008;181(3):551–65. doi:10.1083/jcb.200711002.
   PubMed Web of Science ®Google Scholar
• Walz R, Amaral OB, Rockenbach IC, Roesler R, Izquierdo I, Cavalheiro EA, Martins VR, Brentani RR. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia. 1999;40(12):1679–82. doi:10.1111/j.1528-1157.1999.tb01583.x.
   PubMed Web of Science ®Google Scholar
• Weise J, Sandau R, Schwarting S. Deletion of cellular prion protein results in reduced akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury. Stroke. 2006;37(5):1296–300. doi:10.1161/01.STR.0000217262.03192.d4.
   PubMed Web of Science ®Google Scholar
• Westergard L, Christensen HM, Harris DA. The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta. 2007;1772(6):629–44. doi:10.1016/j.bbadis.2007.02.011.
   PubMed Web of Science ®Google Scholar
• Banks WA, Robinson SM, Diaz-Espinoza R. Transport of prion protein across the blood-brain barrier. Exp Neurol. 2009;218(1):162–67. doi:10.1016/j.expneurol.2009.04.025.
   PubMed Web of Science ®Google Scholar
• Parizek P, Roeckl C, Weber J. Similar turnover and shedding of the cellular prion protein in primary lymphoid and neuronal cells. J Biol Chem. 2001;276(48):44627–32. doi:10.1074/jbc.M107458200.
   PubMed Web of Science ®Google Scholar
• Mitsios N, Saka M, Krupinski J. Cellular prion protein is increased in the plasma and peri-infarcted brain tissue after acute stroke. J Neurosci Res. 2007;85(3):602–11. doi:10.1002/jnr.21142.
   PubMed Web of Science ®Google Scholar
• Wang KK, Zoltewicz JS, Chiu A. Release of full-length PrP(C) from cultured neurons following neurotoxic challenges. Front Neurol. 2012;3:147. doi:10.3389/fneur.2012.00147.
   PubMedGoogle Scholar
• Altmeppen HC, Prox J, Puig B. Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol Neurodegener. 2011;6(1):36. doi:10.1186/1750-1326-6-36.
   PubMed Web of Science ®Google Scholar
• Prado MA, Alves-Silva J, Magalhaes AC. PrPc on the road: trafficking of the cellular prion protein. J Neurochem. 2004;88(4):769–81. doi:10.1046/j.1471-4159.2003.02199.x.
   PubMed Web of Science ®Google Scholar
• Sarnataro D, Caputo A, Casanova P. Lipid rafts and clathrin cooperate in the internalization of PrP in epithelial FRT cells. PloS One. 2009;4(6):e5829. doi:10.1371/journal.pone.0005829.
   PubMed Web of Science ®Google Scholar
• Taylor DR, Parkin ET, Cocklin SL. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J Biol Chem. 2009;284(34):22590–600. doi:10.1074/jbc.M109.032599.
   PubMed Web of Science ®Google Scholar
• Del Turco D, Schlaudraff J, Bonin M, Deller T. Upregulation of APP, ADAM10 and ADAM17 in the denervated mouse dentate gyrus. PloS One. 2014;9(1):e84962. doi:10.1371/journal.pone.0084962.
   PubMed Web of Science ®Google Scholar
• Phillips LL, Chan JL, Doperalski AE, Reeves TM. Time dependent integration of matrix metalloproteinases and their targeted substrates directs axonal sprouting and synaptogenesis following central nervous system injury. Neural Regen Res. 2014;9(4):362–76. doi:10.4103/1673-5374.128237.
   PubMed Web of Science ®Google Scholar
• Warren KM, Reeves TM, Phillips LL. MT5-MMP, ADAM-10, and N-cadherin act in concert to facilitate synapse reorganization after traumatic brain injury. J Neurotrauma. 2012;29(10):1922–40. doi:10.1089/neu.2012.2383.
   PubMed Web of Science ®Google Scholar
• Rubenstein R, Wang KK, Chiu A. PrP(C) expression and calpain activity independently mediate the effects of closed head injury in mice. Behav Brain Res. Mar. 2018 15;340:29–40. doi:10.1016/j.bbr.2016.04.041.
   PubMed Web of Science ®Google Scholar
• Kural A, Tekin Neijmann S, Toker A, Doğan H, Sever N, Sarıkaya S. Evaluation of rat major cellular prion protein for early diagnosis in experimental rat brain trauma model. Deneysel beyin travması oluşturulan sıçanlarda erken tanı için sellüler prion protein(PrPC)’nin değerlendirilmesi. Ulusal Travma Ve Acil Cerrahi dergisi = Turkish Journal of Trauma & Emergency Surgery : TJTES. 2020;26(1):1‐8. doi:10.5505/tjtes.2018.46923.
   PubMed Web of Science ®Google Scholar
• Zetterberg H, Blennow K. Fluid biomarkers for mild traumatic brain injury and related conditions. Nat Rev Neurol. 2016;12(10):563‐574. doi:10.1038/nrneurol.2016.127.
   Web of Science ®Google Scholar
• Blennow K, Brody DL, Kochanek PM, Levin H, McKee A, Ribbers GM, Yaffe K, Zetterberg H. Traumatic brain injuries. Nat Rev Dis Primers. 2016;2(1):16084. doi:10.1038/nrdp.2016.84.
   PubMed Web of Science ®Google Scholar
• Costello DM, Kaye AH, O’Brien TJ, Shultz SR. Sport related concussion – potential for biomarkers to improve acute management. Journal of Clinical Neuroscience. 2018;56:1–6. doi:10.1016/j.jocn.2018.07.002.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Tsao JW, Stanfill AG. The current state of biomarkers of mild traumatic brain injury. JCI Insight. 2018 11;3(1). doi:10.1172/jci.insight.97105.
   Web of Science ®Google Scholar
• Pérez-Bárcena J, Crespí C, Frontera G, Llompart-Pou JA, Salazar O, Goliney V, Ibáñez J, Bullock MR, De Rivero Vaccari JP. Levels of caspase-1 in cerebrospinal fluid of patients with traumatic brain injury: correlation with intracranial pressure and outcome. J Neurosurg. 2020;1‐6. doi:10.3171/2020.2.JNS193079.
   PubMed Web of Science ®Google Scholar
• Ritchie EV, Emery C, Debert CT. Analysis of serum cortisol to predict recovery in paediatric sport-related concussion. Brain Injury. 2018;32(4):523–28. doi:10.1080/02699052.2018.1429662.
   PubMed Web of Science ®Google Scholar
• Kondo A, Shahpasand K, Mannix R, Qiu J, Moncaster J, Chen C-H, Yao Y, Lin Y-M, Driver JA, Sun Y. Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy. Nature. 2015;523(7561):431‐436. doi:10.1038/nature14658.
   PubMed Web of Science ®Google Scholar
• McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, Daneshvar DH, Lee H-S, Wojtowicz SM, Hall G, Baugh CM. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013;136(Pt 1):43‐64. doi:10.1093/brain/aws307.
   PubMed Web of Science ®Google Scholar
• Slavoaca D, Muresanu D, Birle C. Biomarkers in traumatic brain injury: new concepts [published online ahead of print, 2020 Mar 10]. Neurol Sci. 2020. doi:10.1007/s1007201904238y.
   Web of Science ®Google Scholar
• Anderson T, Hwang J, Munar M, Papa L, Hinson HE, Vaughan A, Rowell SE. Blood-based biomarkers for prediction of intracranial hemorrhage and outcome in patients with moderate or severe traumatic brain injury. J Trauma Acute Care Surg. 2020;89(1):80–86. doi:10.1097/TA.0000000000002706.
   PubMed Web of Science ®Google Scholar
• Gayen M, Bhomia M, Balakathiresan N, Knollmann-Ritschel B. Exosomal microRNAs released by activated astrocytes as potential neuroinflammatory biomarkers. Int J Mol Sci. 2020;21(7):2312. doi:10.3390/ijms21072312.
   PubMed Web of Science ®Google Scholar
• Wang P, Ma H, Zhang Y, Zeng R, Yu J, Liu R, Jin X, Zhao Y. Plasma exosome-derived microRNAs as novel biomarkers of traumatic brain injury in rats. Int J Med Sci. 2020;17(4):437–48. doi:10.7150/ijms.39667.
   PubMed Web of Science ®Google Scholar
• O’Brien WT, Pham L, Symons GF, Monif M, Shultz SR, McDonald SJ. The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target. J Neuroinflammation. 2020;17(1):104. doi:10.1186/s12974-020-01778-5.
   PubMed Web of Science ®Google Scholar
• Hajiaghamemar M, Kilbaugh T, Arbogast KB, Master CL, Margulies SS. Using serum amino acids to predict traumatic brain injury: a systematic approach to utilize multiple biomarkers. Int J Mol Sci. 2020;21(5):1786. doi:10.3390/ijms21051786.
   PubMed Web of Science ®Google Scholar
• Pitkänen A, Paananen T, Kyyriäinen J, Das Gupta S, Heiskanen M, Vuokila N, Bañuelos-Cabrera I, Lapinlampi N, Kajevu N, Andrade P, Ciszek R, Lara-Valderrábano L, Ekolle Ndode-Ekane X, Puhakka N. Biomarkers for posttraumatic epilepsy. Epilepsy Behav 2020 Apr 18;107080. doi:10.1016/j.yebeh.2020.107080
   Google Scholar
• Sweeney MD, Sagare AP, Pachicano M, Harrington MG, Joe E, Chui HC, Schneider LS, Montagne A, Ringman JM, Fagan AM. A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid. Alzheimers Dement. 2020;16(6):821–30. doi:10.1002/alz.12061.
   PubMed Web of Science ®Google Scholar
• Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, Laude H, Raposo G. Cells release prions in association with exosomes. Proc Natl Acad Sci U S A. 2004;101(26):9683–88. doi:10.1073/pnas.0308413101.
   PubMed Web of Science ®Google Scholar
• Keller S, Sanderson MP, Stoeck A, Altevogt P. Exosomes: from biogenesis and secretion to biological function. Immunol Lett. 2006;107(2):102–08. doi:10.1016/j.imlet.2006.09.005.
   PubMed Web of Science ®Google Scholar
• Robinson BD, Tharakan B, Lomas A, Wiggins-Dohlvik K, Alluri H, Shaji CA, Jupiter D, Isbell CL. Exploring blood-brain barrier hyperpermeability and potential biomarkers in traumatic brain injury. Proc (Bayl Univ Med Cent). 2020;33(2):199–204. doi:10.1080/08998280.2020.1727706.
   PubMedGoogle Scholar
• Linsenmeier L, Mohammadi B, Wetzel S, Puig B, Jackson WS, Hartmann A, Uchiyama K, Sakaguchi S, Endres K, Tatzelt J. Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein. Mol Neurodegener. 2018;13(1):18. doi:10.1186/s13024-018-0248-6.
   PubMed Web of Science ®Google Scholar
• Perez-Gonzalez R, Gauthier SA, Kumar A, Levy E. The exosome secretory pathway transports amyloid precursor protein carboxyl-terminal fragments from the cell into the brain extracellular space. J Biol Chem. 2012;287(51):43108–15. doi:10.1074/jbc.M112.404467.
   PubMed Web of Science ®Google Scholar
• Stoeck A, Keller S, Riedle S, Sanderson M, Runz S, Le Naour F, Gutwein P, Ludwig A, Rubinstein E, Altevogt P. A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem J. 2006;393(3):609–18. doi:10.1042/BJ20051013.
   PubMed Web of Science ®Google Scholar
• Heisler FF, Pechmann Y, Wieser I, Altmeppen HC, Veenendaal L, Muhia M, Schweizer M, Glatzel M, Krasemann S, Kneussel M. Muskelin coordinates PrPC lysosome versus exosome targeting and impacts prion disease progression. Neuron. 2018;99(6):1155–1169.e9. doi:10.1016/j.neuron.2018.08.010.
   PubMed Web of Science ®Google Scholar
• Janes PW, Saha N, Barton WA, Kolev MV, Wimmer-Kleikamp SH, Nievergall E, Blobel CP, Himanen J-P, Lackmann M, Nikolov DB. Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell. 2005;123(2):291–304. doi:10.1016/j.cell.2005.08.014.
   PubMed Web of Science ®Google Scholar
• Wetzel S, Seipold L, Saftig P. The metalloproteinase ADAM10: a useful therapeutic target?. Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11):2071–81. doi:10.1016/j.bbamcr.2017.06.005.
   PubMed Web of Science ®Google Scholar